article thumbnail

Henry Ford Health Cardiologists Publish Case Series Study on Heart Valve Procedure

DAIC

These key takeaways from the research letter on IVL-facilitated valvuloplasty for severely calcified mitral valve stenosis are published in the Journal of the American College of Cardiology (JACC) Cardiovascular Interventions. an interventional cardiologist and structural heart disease expert at Henry Ford Health.

article thumbnail

Redo Transcatheter Aortic Valve Implantation in the Lotus Mechanically Expanded Transcatheter Heart Valve: Bench-Top Analysis, Clinical Experience, and Procedural Guidance

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e013296, November 1, 2023. BACKGROUND:Redo transcatheter aortic valve implantation (TAVI) is increasing as patients outlive their transcatheter heart valves (THVs) and present with bioprosthetic valve failure.

article thumbnail

Transcatheter MViR Identified as Reasonable Alternative For Patients With High Surgical Risk

American College of Cardiology

Transcatheter mitral valve-in-ring (MViR) using third-generation balloon-expandable aortic transcatheter heart valves was associated with a significant reduction in mitral regurgitation (MR) and improvement in heart failure symptoms at one year, with the tradeoff of elevated valvular gradients and a high rate of reintervention, according to a recent (..)

article thumbnail

NCDR Analysis Examines Outcomes With Fifth-Generation Balloon Expandable THV

American College of Cardiology

The fifth-generation SAPIEN 3 Ultra Resilia valve (S3UR) transcatheter heart valve (THV), used in TAVR procedures, is associated with lower mean gradients and lower rates of paravalvular leak (PVL) when compared to outcomes from the SAPIEN 3 (S3) and SAPIEN 3 Ultra (S3U) valves, according to a study presented at CRT 2024 and simultaneously published (..)

article thumbnail

Challenges and Future Directions in Redo Aortic Valve Reintervention After Transcatheter Aortic Valve Replacement Failure

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e012966, November 1, 2023. Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients.

article thumbnail

Hemodynamic Comparison of Resilia and Sapien 3/Ultra Transcatheter Heart Valves in Transcatheter Aortic Valve Replacement

Circulation: Cardiovascular Interventions

Circulation: Cardiovascular Interventions, Ahead of Print.

article thumbnail

Time to TAVI: streamlining the pathway to treatment

Open Heart

The existing treatment pathway for transcatheter aortic valve implantation (TAVI) traditionally relies on tertiary Heart Valve Centre workup. However, this has been associated with delays to treatment, in breach of British Cardiovascular Intervention Society targets. ±64 to 126±257 days, p<0.00001).